language.en-US
  • EN
  • RU
Management of multidrug-resistant tuberculosis and renal failure

12th webinar of the Virtual Medical Consilium (VMC) on Tuberculosis, from 17th December 2021. 

The webinar agenda includes: 

- Welcoming remarks. Dr Askar Yedilbayev and Mr Oleksandr Korotych, TB Team, Joint Infectious Diseases Unit, Division of Country Health Programmes, WHO Regional Office for Europe, Copenhagen, Denmark. 

- Is there any role for injectable agents in management of MDR/RR-TB? Dr Michel Rich, Associate Professor at Harvard Medical School; Associate Physician at Partners In Health, USA. 

- Management of MDR/RR-TB patients with kidney failure. Dr Elmira Berikova, VMC expert, Kazakhstan. 

- Experience of Belarus in management of MDR/RR-TB patient with kidney failure within mSTR operational research. Dr Natalya Yatskevich, Republic Scientific and Practical Center of Pulmonology and Tuberculosis, Belarus

1. Is there any role for injectable_ENG.pdf 1. Is there any role for injectable_RUS.pdf 2. Management of MDR_RR-TB Patients With Renal Failure_ENG.pdf 2. Ведение МЛУ_РУ-ТБ пациентов_RUS.pdf 3. Clinical case_ENG.pdf 3. Клинический случай_RUS.pdf